Drugs (Prices Control) Order, 2013

.........................................................................................................................
As Amended by The Drugs (Price Control) Amendment Order, 2016 dt. 10-3-2016, w.e.f. 10-3-2016
Alongwith
The National Pharmaceuticals Pricing Policy, 2012 (NPPP-2012)
Contents
The Drugs (Prices Control) Order, 2013
1.   Short title and commencement
2.   Definitions
3.   Directors to manufactures of active pharmaceutical ingredients or bulk drugs or formulations
4.   Calculation of ceiling price of a scheduled formulation
5.   Calculation of retail price of a new drug for existing manufactures of scheduled formulations
6.   Ceiling price of a scheduled formulation in case of no reduction in
      price due to absence of competition
7.   Margin to retailer
8.   Maximum retail price
9.   Reference data and source of market based data
10. Pricing of the formulations covered under Drugs (Prices Control) Order, 1995
11.  Ceiling price or retail price of a pack
12.  Price of formulations (branded or generic version) listed in the National List of Essential
       Medicines, launched by a manufacturer
13.  Price of scheduled formulations for the existing manufacturers
14.  Fixation of ceiling price of scheduled formulations
15.  Fixation of retail price of a new drug for existing manufacturers of scheduled formulations
16.  Revision of ceiling price of scheduled formulations
17.  Amendment of the list of scheduled formulation
18.  Revision of ceiling price on the basis of moving annual turnover (MAT)
19.  Fixation of ceiling price of a drug under certain circumstances
20.  Monitoring the prices of non-scheduled formulations
21.  Monitoring the availability of scheduled formulations
22.  Recovery of dues accrued under the Drugs (Prices Control) Order, 1979 and to deposit the
      same into the Drugs Prices Equalisation Account
23.  Recovery of overcharged amount under Drugs Prices Control Orders, 1987 and 1995
24.  Carrying into effect the price fixed or revised by the Government
25.  Display of non-scheduled formulations and price list thereof
26.  Control of sale prices of formulations
27.  Sale of split quantities of formulations
28.  Manufacturer, distributor of dealer not refuse sale of drug
29.  Maintenance of records and production thereof for inspection
30.  Power of entry, search and seizure
31.  Power to review
32.  Non-application of the provisions of this order in certain cases.
Schedule I
Schedule II  Form I - V
National Pharmaceuticals Pricing Policy, 2012 (NPPP-2012)
1.  Preamble and Background
2.  Objectives of the Present Policy
3.  Key Principles of National Pharmaceuticals Pricing Policy, 2012
4.  Principles for Drugs Price Control and Determination in NPPP-2012
5.  Essential issues for the implementation of the policy
6.  Implementation
.........................................................................................................................